Chargement en cours...
Pilot Study of Oral Valganciclovir Therapy in Patients With Classic Kaposi Sarcoma
We conducted a clinical trial of oral valganciclovir, a drug with in vitro activity against Kaposi sarcoma (KS)–associated herpesvirus (KSHV), in classic KS. Five human immunodeficiency virus–seronegative participants received valganciclovir for up to six 4-week cycles at doses used for cytomegalovi...
Enregistré dans:
| Publié dans: | J Infect Dis |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Oxford University Press
2011
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6767870/ https://ncbi.nlm.nih.gov/pubmed/21450998 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiq177 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|